Correction: The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease Progression

Cureus. 2023 Feb 13;15(2):c101. doi: 10.7759/cureus.c101. eCollection 2023 Feb.

Authors

Affiliations

¹ Oncology, Champalimaud Foundation, Lisbon, PRT.
² Lung Unit, Champalimaud Foundation, Lisbon, PRT.
³ Dermatology, Champalimaud Foundation, Lisbon, PRT.
⁴ Faculty of Pharmacy, University of Lisbon, Lisbon, PRT.
⁵ Health & Technology Research Center, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Lisbon, PRT.

Abstract

[This corrects the article DOI: 10.7759/cureus.26729.].

Copyright © 2023, Pantarotto et al.

Publication types

Published Erratum